Volume 194, number 12: Finding the Cause of Kawasaki Disease: A Pediatric Infectious Diseases Research Priority
14th Nov 2006, 00:59 GMT
Volume 194, number 12: Finding the Cause of Kawasaki Disease: A Pediatric Infectious Diseases Research Priority related news:
- Active Surveillance for Candidemia, Australia — Medscape Infectious Diseases Headlines
- ICD-9 Codes and Surveillance for Clostridium Difficile-associated Disease — Medscape PublicHealth Headlines
- Varicella Surveillance Practices --- United States, 2004 — Medscape Infectious Diseases Headlines
- Volume 194, number 12: Reviewers — J Infect Dis Latest Issue
- Mainland, HK, Macao hold joint cross-border emergency exercise on infectious diseases — People's Daily Online
- Volume 194, number 12: Blinded Case-Control Study of the Relationship between Human Coronavirus NL63 and Kawasaki Syndrome — J Infect Dis Latest Issue
- ACT-AD Coalition Calls FDA's New Focus on Neurological Diseases a Positive 1st Step — FDA News News from StratCenter.com
- Mainland, HK, Macao Hold Joint Exercise on Diseases — CRIENGLISH.com: China News
- Tacere Therapeutics Appoints Vice President, Research and Development — RedOrbit News - Health
- Chronic Diseases Threaten Economies Across The Globe — Health News from Medical News Today
Latest news from J Infect Dis Latest Issue:
- Volume 194, number 12: Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector
- Volume 194, number 12: Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 DNA Candidate Vaccine
- Volume 194, number 12: Quantification of Viral Inactivation by Photochemical Treatment with Amotosalen and UV A Light, Using a Novel Polymerase Chain Reaction Inhibition Method with Preamplification
- Volume 194, number 12: Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV-1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138
- Volume 194, number 12: Evaluation of Purified Taenia solium Glycoproteins and Recombinant Antigens in the Serologic Detection of Human and Swine Cysticercosis
- Volume 194, number 12: Phase 1 Clinical Trials of the National Institutes of Health Vaccine Research Center HIV/AIDS Candidate Vaccines
- Volume 194, number 12: Is There a Safe Age for Vaccinating Infants with Tetravalent Rhesus-Human Reassortant Rotavirus Vaccine?
- Volume 194, number 12: Reply to Gargiullo et al.
- Volume 194, number 12: Is Panton-Valentine Leukocidin the Major Virulence Determinant in Community-Associated Methicillin-Resistant Staphylococcus aureus Disease?
- Volume 194, number 12: Human Cytolytic T Cell Recognition of Yersinia pestis Virulence Proteins That Target Innate Immune Responses